Cantor Fitzgerald analyst Sarah James maintained a Hold rating on CVS Health (CVS – Research Report) yesterday and set a price target of ...

CVS Health (CVS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Erin Wright from ...

CVS Health Chief Executive Officer Karen Lynch has stepped down as the top executive and will be replaced by David Joyner, who has been in charge of the company’s Caremark pharmacy benefit firm ...

In September, the Federal Trade Commission took aim at big pharmacy benefits managers, including CVS subsidiary Caremark, accusing them of inflating insulin prices. “We are not surprised by the ...

The company has also been evaluating whether its pharmacy benefits manager unit, CVS Caremark, which manages drug benefits for health plans, should be housed within the retail unit or under ...

CVS Health has a new CEO: David Joyner, a seasoned veteran in the healthcare industry, is stepping into the challenging role. He takes the helm during a turbulent period for CVS, as it grapples ...

The Caremark pharmacy benefits management business that Joyner led is under scrutiny from the Federal Trade Commission, which alleged CVS and its rivals drove up insulin prices. Congress is ...

Lynch will be replaced by CVS Caremark president David Joyner, who will attempt to steer the health care giant through a worsening environment of rising medical costs. CVS, which had cut its ...

CVS Health said Friday that it has replaced chief executive Karen Lynch, abruptly ending a turbulent tenure during which she struggled to knit together its retail pharmacies and other businesses ...

The Caremark pharmacy benefits management business that Joyner led is under scrutiny from the Federal Trade Commission, which alleged CVS and its rivals drove up insulin prices. Congress is ...